Sunflower Pharmaceutical Group (002737.SZ) plans to invest 10 million yuan in setting up a subsidiary in Hubei.
Aibiao Pharmaceutical Co., Ltd. (002737.SZ) announced that the company has decided to use their own funds of 10 million yuan to invest in the establishment of a wholly-owned subsidiary, Aibiao Pharmaceutical Group (Hubei) Pharmaceutical Co., Ltd. (provisional).
Sunflower Pharmaceutical Group (002737.SZ) announced that the company has decided to invest 10 million yuan of its own funds to establish a wholly-owned subsidiary, Sunflower Pharmaceutical Group (Hubei) Medicine Co., Ltd. (pending).
The establishment of the wholly-owned subsidiary Hubei Medicine Company is part of the company's strategic plan to "refine the group, solidify the subsidiaries," promote independent accounting and operations of various marketing system models and business sectors, strengthen precise resource allocation, unleash the organization's internal dynamics, and enhance overall operational efficiency of the company.
Related Articles
HK Stock Market Move | VOYAH AUTO (07489) surged more than 11% in the afternoon with over 15,000 new vehicles delivered in March, an almost 80% increase compared to the previous month.
In 2026, the new NIO 5566 model will be launched, and the Hong Kong stock market closed at noon skyrocketed by over 9%.
Poly Property (00119) 2025 Annual Report: Continuous optimization of structure, sales among top fifteen
HK Stock Market Move | VOYAH AUTO (07489) surged more than 11% in the afternoon with over 15,000 new vehicles delivered in March, an almost 80% increase compared to the previous month.
In 2026, the new NIO 5566 model will be launched, and the Hong Kong stock market closed at noon skyrocketed by over 9%.
Poly Property (00119) 2025 Annual Report: Continuous optimization of structure, sales among top fifteen
